Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
Internal Medicine (Tokyo, Japan)|March 8, 2021
Eribulin Mesylate-related Multifocal Demyelinating Neuropathy with Myokymia in a Breast Cancer PatientMarie Tsunogae, Satoru Fujiwara, Yuma Shiomi, et al.Journal of the Neurological Sciences|May 17, 2011
Pre-admission CHADS2 score is related to severity and outcome of strokeShoichiro Sato, Yukako Yazawa, Ryo Itabashi, et al.No Shinkei Geka. Neurological Surgery|March 19, 2005
[MRA volume rendering for surgical planning of unruptured intracranial cerebral aneurysms]Ayumi Narisawa, Hiroshi Syamoto, Hiroshi Karibe, et al.Brain and Nerve = Shinkei Kenkyu No Shinpo|June 15, 2021
[Bacterial Meningitis and Suppurative Thrombophlebitis after Trigger Point Injections: A Case Report]Yuma Shiomi, Satoru Fujiwara, Yoshiki Morihisa, et al.Journal of Molecular Biology|September 8, 2004
Conformational changes of troponin C within the thin filaments detected by neutron scatteringFumiko Matsumoto, Kouji Makino, Kayo Maeda, et al.The American Journal of Emergency Medicine|June 9, 2022
The necessity of lumbar puncture in adult emergency patients with fever-associated seizuresDaisuke Mizu, Yoshinori Matsuoka, Ji-Young Huh, et al.Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|February 27, 2025
A visual journey through medium vessel occlusion strokes: From diagnosis to treatmentAlexander Stebner, Salome L Bosshart, Satoru Fujiwara, et al.Stroke|March 3, 2012
Prevalence and length of recovery of pusher syndrome based on cerebral hemispheric lesion side in patients with acute strokeHiroaki Abe, Takeo Kondo, Yutaka Oouchida, et al.Rinsho Shinkeigaku = Clinical Neurology|March 17, 2011
[Ocular ischemic syndrome improved by stent placement for stenosis at the orifice of the left common carotid artery]Yukako Yazawa, Shoichiro Sato, Ryo Itabashi, et al.Thoracic Cancer|June 26, 2024
Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinibYuki Sato, Yoshiharu Sato, Kei Irie, et al.Pageof 11